You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: February 22, 2024

NIPENT Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Nipent, and what generic alternatives are available?

Nipent is a drug marketed by Hospira Inc and is included in one NDA.

The generic ingredient in NIPENT is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nipent

A generic version of NIPENT was approved as pentostatin by WEST-WARD PHARMS INT on August 7th, 2007.

  Try a Trial

Summary for NIPENT
Drug patent expirations by year for NIPENT
Recent Clinical Trials for NIPENT

Identify potential brand extensions & 505(b)(2) entrants

National Cancer Institute (NCI)Phase 1
City of Hope Medical CenterPhase 1
California Institute for Regenerative Medicine (CIRM)Phase 1

See all NIPENT clinical trials

Pharmacology for NIPENT

US Patents and Regulatory Information for NIPENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc NIPENT pentostatin INJECTABLE;INJECTION 020122-001 Oct 11, 1991 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.